Kulkarni Samarth Insider Trading Activity
Kulkarni Samarth has been net-selling over the last 12 months with 0 purchases and 10 sales across 1 company.
CRSP is the most-traded position with 10 trades. The largest single transaction was a sale of CRSP for $3.6M on Jan 22, 2026.
Performance Scorecard
Forward stock performance after each transaction by Kulkarni Samarth. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | +1.5% | 50% | 10 |
| 90 days | — | +1.2% | 60% | 10 |
| 120 days | — | +6.5% | 60% | 10 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersCRSP · CRISPR Therapeutics AG
🔒 Subscribe to see trade entries
Pro members see exactly when Kulkarni Samarth bought and sold CRSP.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Mar 23, 2026 | CRSP | Sell | 10,020 | $46.78 | $469K | −3.8% | CEO | |
Mar 16, 2026 | CRSP | Sell | 10,349 | $48.26 | $499K | −4.0% | CEO | |
Mar 11, 2026 | CRSP | Sell | 9,798 | $52.80 | $517K | −4.0% | CEO | |
Feb 19, 2026 | CRSP | Sell | 6,967 | $52.58 | $366K | −3.0% | CEO | |
Jan 22, 2026 | CRSP | Sell | 60,000 | $60.23 | $3.6M | −30.9% | CEO | |
Jan 20, 2026 | CRSP | Sell | 8,567 | $52.10 | $446K | −4.2% | CEO | |
Jan 20, 2026 | CRSP | Sell | 21,433 | $51.61 | $1.1M | −9.6% | CEO | |
Oct 17, 2025 | CRSP | Sell | 50,895 | $67.91 | $3.5M | −16.7% | CEO | |
Oct 14, 2025 | CRSP | Sell | 4,242 | $66.60 | $283K | −2.0% | CEO | |
Aug 18, 2025 | CRSP | Sell | 13,081 | $58.15 | $761K | −5.9% | CEO |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | 10 | $11.5M |
Other insiders at CRISPR Therapeutics AG
4 other tracked filers at CRSP.